# Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms

> **NCT01518322** · — · COMPLETED · sponsor: **Aerocrine AB** · enrollment: 235 (actual)

## Conditions studied

- Asthma

## Interventions

- **DEVICE:** NIOX MINO®

## Key facts

- **NCT ID:** NCT01518322
- **Lead sponsor:** Aerocrine AB
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 235 (ACTUAL)
- **Last updated:** 2013-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01518322

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01518322, "Impact of FeNO Measured With the NIOX MINO® Device in Identifying Asthma Among Patients With Prolonged Respiratory Symptoms". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01518322. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*